September 20, 2023
The Federal Circuit on Wednesday relied on the high court's recent Amgen ruling to side with a Delaware federal court decision that let a Roche subsidiary off the hook in an infringement case over its blockbuster hemophilia drug Hemlibra.
June 13, 2022
Baxalta Inc. has urged the Federal Circuit to revive an antibody patent invalidated by Circuit Judge Timothy Dyk while sitting in Delaware, saying the ruling wrongly declares the field of antibodies "inherently unpredictable" and therefore not patentable.